FAST NEWS: Shanghai Junshi Biosciences Expects its 2021 Loss to Narrow
The latest: Shanghai Junshi Biosciences Co., Ltd. (1877.HK, 688180.SH) announced its 2021 results forecast late Friday, estimating its net loss would be 736 million yuan ($115.7 million), narrowing from 933…
RELATED ARTICLES
-
ECARX reports its first profit, expects added revenue from Volkswagen tie-up
ECX.US - As Covid drug cash dwindles, Vigonvita targets new remedies
- Shanghai Able’s renewed IPO plan hobbled by weak appetite for new tech listings
-
Despite slumping revenue, Shanghai Refire cruises on government support
2570.HK
- Shanghai family feud ties up $1 billion in property, offers lesson for investors
-
Its knuckles rapped, recovering Gaotu springs back to the black
GOTU.US
